Literature DB >> 9431281

The impact of influenza epidemics on mortality: introducing a severity index.

L Simonsen1, M J Clarke, G D Williamson, D F Stroup, N H Arden, L B Schonberger.   

Abstract

OBJECTIVES: The purpose of this study was to assess the impact of recent influenza epidemics on mortality in the United States and to develop an index for comparing the severity of individual epidemics.
METHODS: A cyclical regression model was applied to weekly national vital statistics from 1972 through 1992 to estimate excesses in pneumonia and influenza mortality and all-cause mortality for each influenza season. Each season was categorized on the basis of increments of 2000 pneumonia and influenza excess deaths, and each of these severity categories was correlated with a range of all-cause excess mortality.
RESULTS: Each of the 20 influenza seasons studied was associated with an average of 5600 pneumonia and influenza excess deaths (range, 0-11,800) and 21,300 all-cause excess deaths (range, 0-47,200). Most influenza A(H3N2) seasons fell into severity categories 4 to 6 (23,000-45,000 all-cause excess deaths), whereas most A(H1N1) and B seasons were ranked in categories 1 to 3 (0-23,000 such deaths).
CONCLUSIONS: From 1972 through 1992, influenza epidemics accounted for a total of 426,000 deaths in the United States, many times more than those associated with recent pandemics. The influenza epidemic severity index was useful for categorizing severity and provided improved seasonal estimates of the total number of influenza-related deaths.

Entities:  

Mesh:

Year:  1997        PMID: 9431281      PMCID: PMC1381234          DOI: 10.2105/ajph.87.12.1944

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

2.  Trends and epidemics of influenza and pneumonia: 1918-1951.

Authors:  S D COLLINS; J LEHMANN
Journal:  Public Health Rep       Date:  1951-11-16       Impact factor: 2.792

3.  A method for timely assessment of influenza-associated mortality in the United States.

Authors:  L Simonsen; M J Clarke; D F Stroup; G D Williamson; N H Arden; N J Cox
Journal:  Epidemiology       Date:  1997-07       Impact factor: 4.822

4.  Methods for current statistical analysis of excess pneumonia-influenza deaths.

Authors:  Robert E Serfling
Journal:  Public Health Rep       Date:  1963-06       Impact factor: 2.792

5.  Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962-1983.

Authors:  D F Stroup; S B Thacker; J L Herndon
Journal:  Stat Med       Date:  1988-10       Impact factor: 2.373

6.  Excess mortality from epidemic influenza, 1957-1966.

Authors:  J Housworth; A D Langmuir
Journal:  Am J Epidemiol       Date:  1974-07       Impact factor: 4.897

7.  An evaluation of influenza mortality surveillance, 1962-1979. I. Time series forecasts of expected pneumonia and influenza deaths.

Authors:  K Choi; S B Thacker
Journal:  Am J Epidemiol       Date:  1981-03       Impact factor: 4.897

8.  Mortality during influenza epidemics in the United States, 1967-1978.

Authors:  K Choi; S B Thacker
Journal:  Am J Public Health       Date:  1982-11       Impact factor: 9.308

9.  Mortality and influenza.

Authors:  W P Glezen; A A Payne; D N Snyder; T D Downs
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

10.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

Authors:  K J Lui; A P Kendal
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

View more
  203 in total

Review 1.  Individual and community impact of influenza.

Authors:  A S Monto
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  Influenza vaccination in 29 countries. An update to 1997.

Authors:  F Ambrosch; D S Fedson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

3.  Value of ICD-9 coded chief complaints for detection of epidemics.

Authors:  F C Tsui; M M Wagner; V Dato; C C Chang
Journal:  Proc AMIA Symp       Date:  2001

4.  Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60.

Authors:  Hong Jin; Helen Zhou; Bin Lu; George Kemble
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 5.  Immunity to influenza: the challenges of protecting an aging population.

Authors:  Jacqueline M Katz; Julie Plowden; Mary Renshaw-Hoelscher; Xiuhua Lu; Terrence M Tumpey; Suryaprakash Sambhara
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Winter North Atlantic Oscillation, temperature and ischaemic heart disease mortality in three English counties.

Authors:  Glenn R McGregor
Journal:  Int J Biometeorol       Date:  2004-08-03       Impact factor: 3.787

Review 7.  Influenza and cardiovascular disease: is there a causal relationship?

Authors:  Mohammad Madjid; Ibrahim Aboshady; Imran Awan; Silvio Litovsky; S Ward Casscells
Journal:  Tex Heart Inst J       Date:  2004

8.  Influenza update: a review of currently available vaccines.

Authors:  Lisa R Clayville
Journal:  P T       Date:  2011-10

9.  Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians.

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Adam Meijer; Wilfrid van Pelt; Nico J D Nagelkerke; Gé A Donker; Marianne A B van der Sande; Marion P G Koopmans
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

Review 10.  Contrasting the epidemiological and evolutionary dynamics of influenza spatial transmission.

Authors:  Cécile Viboud; Martha I Nelson; Yi Tan; Edward C Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.